Australia markets closed

Nurosene Health Inc. (8TV.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.0940-0.0310 (-24.80%)
As of 04:42PM CEST. Market open.
Full screen
Previous close0.1250
Open0.1030
Bid0.0935 x N/A
Ask0.2900 x N/A
Day's range0.0885 - 0.1030
52-week range0.0885 - 1.3400
Volume7,000
Avg. volume107
Market cap5.231M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.2030
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    NUROSENE & CYCLICA PARTNER TO DEVELOP NOVEL DRUGS FOR NEURODEGENERATIVE DISEASES

    Nurosene Health Inc. ("Nurosene" or the "Company") (CSE: MEND) (Frankfurt: 8TV) (OTC: MNNDF), a healthtech company focused on delivering innovative AI based technology solutions for mental performance and wellness, is partnering, via its wholly owned subsidiary NetraMark Corp. ("NetraMark"), with Cyclica Inc. ("Cyclica"), a neo-biotech with the vision to advance the most robust and sustainable drug discovery pipeline. This partnership agreement, signed February 7th, 2022, will leverage NetraHeal